STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) and laser-based procedures, such as LASIK to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

STAAR Surgical Company

BTIG analyst Ryan Zimmerman maintained a Hold rating on Staar Surgical yesterday. The company’s shares closed yesterday at $27.40. According to Tip...

BTIG Remains a Hold on Staar Surgical (STAA)

Staar Surgical Company ( ($STAA) ) has released its Q3 earnings. Here is a breakdown of the information Staar Surgical Company presented to its inv...

STAAR Surgical Reports Q3 2025 Financial Results

The latest announcement is out from Staar Surgical ( ($STAA) ). On November 7, 2025, STAAR Surgical Company announced an amendment to its merger ag...

Staar Surgical Amends Merger Agreement with Alcon

In a report released today, John Young CFA from Canaccord Genuity maintained a Hold rating on Staar Surgical, with a price target of $28.00. Young ...

Canaccord Genuity Remains a Hold on Staar Surgical (STAA)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Staar Surgical (STAA – Research Report), Keros Therapeutics (KROS...

Analysts Offer Insights on Healthcare Companies: Staar Surgical (STAA), Keros Therapeutics (KROS) and Electrocore (ECOR)

Staar Surgical ( ($STAA) ) just unveiled an announcement. On October 27, 2025, STAAR Surgical announced the postponement of its special meeting of ...

Current Yield	N/A	Payout Ratio	0.00%
Annual DPS	$0.00	Growth Streak	0 years
Ex-Dividend	Invalid Date	Pay Date	Invalid Date
Frequency	NA	Quarterly Est	$0.00

	A	B	C	D
1	Symbol	Price	Change	Volume
2	STAA	$28.00	+2.38%	2.02M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	STAA	$28.00	+2.4%	2.02M
3
4
5
6

STAA

STAA

Dividend Overview

Get STAAR Surgical Company Data in Excel

Get STAAR Surgical Company Data in Excel